Aerobiotix Announces Raise of $25M Growth Equity Financing Led by Healthcare Investment Firm Vivo Capital
Aerobiotix, a pioneer in airborne infection control products that provide real-time, in room solutions for hospitals, ASCs, long…
Browsing Tag
Vivo Capital is an investment firm focused on the healthcare industry. Vivo was formed in 1996 and is currently investing in companies from its $1.4B Vivo Capital Fund IX into promising private healthcare companies and from its $635M Vivo Opportunity Fund into promising public healthcare companies.
The global healthcare investment firm has approximately $5.8 Billion in assets under their management with an investment history of over 25 years.
Vivo has three fund vehicles including Private Equity, Public Equity and Venture Capital.